RGS9-2 modulates sensory and mood related symptoms of neuropathic pain
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 115, 43-48
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Correlation Between Ventral Striatal Catecholamine Content and Nociceptive Thresholds in Neuropathic MiceThe Journal of Pain, 2014
- Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: A potential biomarker of efficacyPain, 2014
- Nucleus Accumbens-Specific Interventions in RGS9-2 Activity Modulate Responses to MorphineNeuropsychopharmacology, 2014
- Regulator of G protein signaling 4 is a crucial modulator of antidepressant drug action in depression and neuropathic pain modelsProceedings of the National Academy of Sciences, 2013
- Essential role for RGS9 in opiate actionProceedings of the National Academy of Sciences, 2003
- Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysisThe Journal of Pain, 2003
- RGS9 Modulates Dopamine Signaling in the Basal GangliaNeuron, 2003
- Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein SignalingPharmacological Reviews, 2002
- Lesion and electrical stimulation of the ventral tegmental area modify persistent nociceptive behavior in the ratBrain Research, 2001
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 1988